FASEB J.
| [0003]
|
Science
| [0003]
|
EMBO J.
| [0003]
|
Adv. Cancer Res.
| [0008]
|
Nat. Rev. Cancer
| [0008]
|
Mol. Biol. Cell
| [0008]
|
Annu. Rev. Immunol
| [0008]
|
Biochim Biophys Acta
| [0008]
|
Biochemistry (Moscow)
| [0008]
[0010]
[0011]
|
Annu Rev Cell Dev Biol
| [0008]
[0008]
|
Nature
| [0008]
|
Nature
| [0009]
|
Oncogene
| [0009]
|
Proc Natl Acad Sci U S A
| [0009]
|
Proc Natl Acad Sci U S A
| [0009]
|
Oncogene
| [0010]
|
Oncogene
| [0010]
|
Curr. Pharm. Des.
| [0010]
|
Nat Genet
| [0010]
|
Biochem Biophys Res Conumun
| [0010]
|
J. Clin. Invest.
| [0010]
|
Biochem. Biophys. Res.
| [0010]
|
Adv. Cancer Res.
| [0010]
|
Leukemia
| [0010]
|
Drugs of the Future
| [0010]
[0011]
[0015]
|
Proc. Natl. Acad, Sci. USA
| [0010]
|
Oncogene
| [0010]
|
European Journal of Cancer
| [0010]
|
Cancer Research
| [0010]
|
Gut
| [0010]
|
Clin. Cancer Research
| [0010]
|
Oncogene
| [0010]
|
Biochim. Biophys. Acta
| [0010]
|
Jpn J Cancer Res
| [0010]
|
Exp. Cell Res.
| [0011]
|
Cancer Res.
| [0011]
|
Oncogene
| [0011]
|
Clin, Cancer Res.
| [0011]
|
Cell Growth Diff.
| [0011]
|
Nature Medicine
| [0011]
[0019]
|
J. Clin. Invest.
| [0011]
|
Cell
| [0012]
|
J. Immunol.
| [0012]
|
Nature
| [0012]
|
Nature
| [0013]
|
Biochemistry
| [0014]
|
J. Leukoc. Biol.
| [0015]
|
Mol. Cell. Biol.
| [0016]
|
EMBO J.
| [0018]
|
Mol. Cell. Biol.
| [0018]
|
Biochemistry
| [0018]
|
Trends Pharmacol. Sct.
| [0018]
|
Nat. Med.
| [0018]
|
Cell
| [0019]
|
J Clin. Invest
| [0019]
|
Mol. Biol. Cell
| [0019]
|
Adv. Immunol.
| [0019]
|
J. Clin. Invest.
| [0019]
|
FEBS Lett.
| [0020]
|
J Biol Chein
| [0020]
|
Current Opinion in Immunol.
| [0022]
|
Expert Opin. Ther. Pat.
| [0023]
|
Curr. Opin. Drug Discovery Dev.
| [0023]
|
J. Med. Chem.
| [0023]
|
J. Med. Chem.
| [0023]
|
Protective Groups in Organic Synthesis
| [0072]
|
J. of Med. Chem.
| [0115]
|
Reductions in Organic Chemistry, ACS Monograph
| [0116]
|
J. Med. Chem.
| [0118]
|
Comprehensive Heterocyclic Chemistry
| [0118]
|
March. Advanced Organic Chemistry
| [0118]
|
Advanced Organic Chemistry
| [0120]
|
Comprehensive Organic Transformations
| [0120]
|
J. Med, Chem.
| [0124]
|
J. Med. Chem.
| [0124]
[0125]
|
J. Med. Chem.
| [0124]
|
J. Med. Chem.
| [0124]
|
J. Med Chem.
| [0124]
|
J. Med. Chem.
| [0125]
|
Curr Cancer Drug Targets
| [0157]
|
J. Med. Chem
| [0195]
|